These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12441907)

  • 1. Relation of serum sialic acid to blood coagulation activity in type 2 diabetes.
    Wakabayashi I; Masuda H
    Blood Coagul Fibrinolysis; 2002 Dec; 13(8):691-6. PubMed ID: 12441907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.
    Wakabayashi I; Masuda H
    Thromb Res; 2007; 121(1):95-102. PubMed ID: 17439823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Serum Sialic Acid and Hemostatic Markers in Patients with Type 2 Diabetes Mellitus.
    Zheng N; Shi X; Chen X; Zheng Y
    Clin Lab; 2015; 61(5-6):607-14. PubMed ID: 26118196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent relation of serum sialic acid concentration to aortic pulse wave velocity in type 2 diabetes.
    Wakabayashi I; Masuda H
    Diabetes Metab; 2004 Nov; 30(5):441-9. PubMed ID: 15671913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    J Thromb Thrombolysis; 2009 Jan; 27(1):29-35. PubMed ID: 17929144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
    Abdella N; Akanji AO; Mojiminiyi OA; Al Assoussi A; Moussa M
    Diabetes Res Clin Pract; 2000 Sep; 50(1):65-72. PubMed ID: 10936670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA.
    Lindberg G; Iso H; Råstam L; Lundblad A; Folsom AR
    Int J Epidemiol; 1997 Feb; 26(1):58-63. PubMed ID: 9126503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sialic acid concentration and atherosclerotic risk factors.
    Wakabayashi I; Sakamoto K; Yoshimoto S; Kakishita E
    J Atheroscler Thromb; 1994; 1(2):113-7. PubMed ID: 9222879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related change in relationship between body-mass index, serum sialic acid, and atherogenic risk factors.
    Wakabayashi I
    J Atheroscler Thromb; 1998; 5(2):60-5. PubMed ID: 10855559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.
    Woodward M; Lowe GD; Rumley A; Tunstall-Pedoe H; Philippou H; Lane DA; Morrison CE
    Br J Haematol; 1997 Jun; 97(4):785-97. PubMed ID: 9217177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus.
    Crook MA; Couchman S; Tutt P
    Blood Coagul Fibrinolysis; 1996 Sep; 7(6):586-9. PubMed ID: 8899146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum levels of sialic acid in patients with type 1 diabetes mellitus in relation to the incidence of late complications].
    Spunda J; Neumann M; Bartásková D; Kvapil M
    Cas Lek Cesk; 1996 Nov; 135(22):723-5. PubMed ID: 8998824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
    Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.
    Sechi LA; De Marchi S
    J Investig Med; 2001 Jan; 49(1):12-20. PubMed ID: 11217142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus.
    Ebara S; Marumo M; Mukai J; Ohki M; Uchida K; Wakabayashi I
    J Thromb Thrombolysis; 2018 Feb; 45(2):200-205. PubMed ID: 29247447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation abnormalities and the usefulness of D-dimer level for detecting intracardiac thrombosis in adult Fontan patients.
    Takeuchi D; Inai K; Shinohara T; Nakanishi T; Park IS
    Int J Cardiol; 2016 Dec; 224():139-144. PubMed ID: 27648983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.